Evaluation of the prognostic utility of miRNA and multiple genetic markers in stage IIA colon cancer.

Elizabeth Mambo,Tiffany Sanford,Kalyan Buddavarapu,Alex T. Adai,Paul A. Lebourgeois,Karen Rasmussan,Lana X. Garmire

Evaluation of the prognostic utility of miRNA and multiple genetic markers in stage IIA colon cancer.

2017

Elizabeth Mambo
Tiffany Sanford
Kalyan Buddavarapu
Alex T. Adai
Paul A. Lebourgeois
Karen Rasmussan
Lana X. Garmire

3630 Background: The variable prognoses of stage II colon cancer subjects have provoked a therapeutic dilemma of who should receive adjuvant therapy. Presently, prognosis is evaluated on often subj...

Keywords:

Genetic marker
Pathology
Stage IIA Colon Cancer
Adjuvant therapy
Oncology
Stage ii colon cancer
microRNA
Internal medicine
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations